Practical advantages of contrast-enhanced ultrasound in abdominopelvic radiology
Computed tomography (CT) and magnetic resonance imaging (MRI) are two of the workhorse modalities of abdominopelvic radiology. However, these modalities are not without patient- and technique-specific limitations that may prevent a timely and accurate diagnosis. Contrast-enhanced ultrasound (CEUS) is an effective, rapid, and cost-effective imaging modality with expanding clinical utility in the United States. In this pictorial essay, we provide a case-based discussion demonstrating the practical advantages of CEUS in evaluating a variety of pathologies in which CT or MRI was precluded or insufficient. Through these advantages, CEUS can serve a complementary role with CT and MRI in comprehensive abdominopelvic radiology.
KeywordsUltrasound Contrast CEUS Contrast allergy Renal dysfunction
Compliance with ethical standards
Research involving human rights
This article does not contain any studies with human participants performed by any of the authors.
Informed consent was not required.
No funding was received for this work. No author reports relevant conflicts of interest. DTF has a research agreement with Philips Ultrasound, and is on the speaker’s bureau for Philips Ultrasound. EGG has a research grant from GE.
Supplementary material 1 (MP4 7453 kb)
Supplementary material 2 (MP4 11526 kb)
- 3.First Approval by U.S. Food and Drug Administration for Contrast Enhanced Ultrasonography of the Liver Received by Bracco Diagnostics Inc. for LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use (2016). Bracco Diagnostics Inc., Monroe TownshipGoogle Scholar
- 4.ACR Committee on Drugs and Contrast Media (2016) ACR manual on contrast media v10.2. ACR website. https://www.acr.org/Clinical-Resources/Contrast-Manual. Accessed 20 Sep 2017
- 5.Benozzi L, Cappelli G, Granito M, et al. (2009) Contrast-enhanced sonography in early kidney graft dysfunction. Transplant Proc 41(4):1214–1215. https://doi.org/10.1016/j.transproceed.2009.03.029 CrossRefPubMedGoogle Scholar
- 9.Haider M, Yessayan L, Venkat KK, et al. (2015) Incidence of contrast-induced nephropathy in kidney transplant recipients. Transplant Proc 47(2):379–383. https://doi.org/10.1016/j.transproceed.2015.01.008 CrossRefPubMedGoogle Scholar
- 14.Piscaglia F, Bolondi L, Italian Society for Ultrasound in M, Biology Study Group on Ultrasound Contrast A (2006) The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32(9):1369–1375. https://doi.org/10.1016/j.ultrasmedbio.2006.05.031 CrossRefPubMedGoogle Scholar
- 16.Bracco Diagnostics Inc. (2016) Lumason prescribing information. Lumason website. https://imaging.bracco.com/us-en/lumason. Accessed 20 Sep 2017
- 17.Sawhney S, Wilson SR (2017) Can ultrasound with contrast enhancement replace nonenhanced computed tomography scans in patients with contraindication to computed tomography contrast agents? Ultrasound Q 33(2):125–132. https://doi.org/10.1097/RUQ.0000000000000271 CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Furlan A, Marin D, Cabassa P, et al. (2012) Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines. Eur J Radiol 81(9):2099–2105. https://doi.org/10.1016/j.ejrad.2011.07.010 CrossRefPubMedGoogle Scholar
- 38.Han J, Liu Y, Han F, et al. (2015) The degree of contrast washout on contrast-enhanced ultrasound in distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma. Ultrasound Med Biol 41(12):3088–3095. https://doi.org/10.1016/j.ultrasmedbio.2015.08.001 CrossRefPubMedGoogle Scholar
- 40.Li R, Yuan MX, Ma KS, et al. (2014) Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis. PLoS ONE 9(5):e98612. https://doi.org/10.1371/journal.pone.0098612 CrossRefPubMedPubMedCentralGoogle Scholar
- 42.Wildner D, Bernatik T, Greis C, et al. (2015) CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients—early or late washout matters: a subanalysis of the DEGUM multicenter trial. Ultraschall Med 36(2):132–139. https://doi.org/10.1055/s-0034-1399147 CrossRefPubMedGoogle Scholar
- 45.Yuan MX, Li R, Zhang XH, et al. (2016) Factors affecting the enhancement patterns of intrahepatic cholangiocarcinoma (ICC) on contrast-enhanced ultrasound (CEUS) and their pathological correlations in patients with a single lesion. Ultraschall Med 37(6):609–618. https://doi.org/10.1055/s-0034-1399485 PubMedGoogle Scholar
- 50.Westwood M, Joore M, Grutters J, et al. (2013) Contrast-enhanced ultrasound using SonoVue(R) (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess 17(16):1–243. https://doi.org/10.3310/hta17160 CrossRefGoogle Scholar